Premium
Moleculin Biotech Inc (MBRX)
NASDAQ
Hot Features
Inscrivez-vous pour des graphiques en temps réel, des outils d'analyse et des prix.
Moleculin Biotech Inc is a clinical-stage pharmaceutical company with a focus on the treatment of highly resistant cancers and viruses through the development of its drug candidates. The company has three core technologies: Annamycin which is a next-generation anthracycline; Immune/Transcription Mod... Moleculin Biotech Inc is a clinical-stage pharmaceutical company with a focus on the treatment of highly resistant cancers and viruses through the development of its drug candidates. The company has three core technologies: Annamycin which is a next-generation anthracycline; Immune/Transcription Modulators, of which WP1066 is a member; and Metabolism/Glycosylation Inhibitors, of which WP1122 is a member. Show more
| Période | Variation | Variation % | Ouver. | Haut | Bas | Moyenne Vol. Quot. | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | -0.4735 | -25.5945945946 | 1.85 | 2.22 | 1.06 | 11329723 | 1.32054487 | CS |
| 4 | -0.3135 | -18.550295858 | 1.69 | 3.6499 | 0.3975 | 16553353 | 1.67829919 | CS |
| 12 | -1.1835 | -46.23046875 | 2.56 | 3.6499 | 0.3975 | 5861270 | 1.680152 | CS |
| 26 | -1.0135 | -42.4058577406 | 2.39 | 3.6499 | 0.3975 | 2554297 | 1.68888615 | CS |
| 52 | -6.7235 | -83.0061728395 | 8.1 | 10.35 | 0.3975 | 1308763 | 1.79015256 | CS |
| 156 | -19.3235 | -93.3502415459 | 20.7 | 30.75 | 0.3975 | 525954 | 3.84974688 | CS |
| 260 | -9.1235 | -86.8904761905 | 10.5 | 131.7 | 0.3975 | 1138797 | 21.79242457 | CS |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
